Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...
News-Medical.Net on MSN
Integrating AI into colon cancer diagnosis improves the speed and accuracy of detection
A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has ...
CNW/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based ...
News-Medical.Net on MSN
Machine learning tool identifies compounds that induce cancer cells into senescence
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled "SAMP ...
Real Engineering on MSN
Could an Algorithm Predicted Cancer Risk
Modern cancer detection often depends on spotting tiny abnormalities in scans, something even trained specialists can miss.
By Kelly Peters,Special to Rice NewsAs artificial intelligence plays an increasingly prominent role in decoding DNA, tracking ...
The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant ...
DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...
Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback